[#item_full_content]
GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement Deal, Stock Surges
2024-10-09T18:21:57-04:00October 9th, 2024|
Related Posts
-
Will Tesla’s robotaxi reveal be more style or substance?
October 9th, 2024 -
South Korea’s Bond Inclusion Win Sets the Market Up for a Lift
October 9th, 2024 -
Morning Bid: Reality check for China stocks, dollar rips higher
October 9th, 2024